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Cardiovascular diseases (CVD) are the leading cause of 
mortality and morbidity worldwide.1 Because several CVD 
have sequelae that significantly impact the life of affected 
individuals, knowing the importance of those diseases, as well 
as their associated factors, is essential to develop preventive 
measures to reduce that impact.2-4
The study published in this issue of the Arquivos Brasileiros 
de Cardiologia5 conducts an epidemiological assessment of 
CVD in Portuguese-speaking countries (PSC) from 1996 to 
2016, being, in that context, unprecedented and relevant. 
Despite some limitations, always present in that type of study, 
the analysis has considerable merit and allows us to draw 
very important conclusions. That study assesses, from an 
innovative perspective, CVD in a set of countries scattered 
around the world, which share a common language and 
cultural base, but have totally distinct geographic locations. 
In that type of analysis, the impact of local aspects, such as 
sanitation structures, health policies, economic and political 
conditions, on the parameters assessed must be properly 
considered, and that study does it in a very elegant way. 
The authors clearly indicate that the relative importance of the 
burden of CVD differs in the different PSC, and they directly 
relate those differences to the socioeconomic conditions of 
the countries. Of the CVD, ischemic heart disease is the major 
cause of death in all PSC, except for Mozambique and Sao 
Tome and Principe. In addition, the authors report that the 
most relevant risk factors for CVD, arterial hypertension and 
dietary factors, are common in the PSC. Furthermore, they 
conclude that "Genetic factors, implicit in the cultural identity, 
the factors inherent in the host, as well as the huge social 
inequality might have contributed to explain the mortality 
rates observed." It is worth noting that the authors report 
the general reduction in mortality from CVD as a common 
denominator among all the PSC, although the intensity of 
that reduction differs in the countries.
The introduction of several therapeutic strategies, such 
as drugs and medical devices, has determined a substantial 
reduction in mortality from CVD in general. In fact, the 
therapeutic and diagnostic advances in the cardiovascular 
field have contributed to an 80% increase in the life 
expectancy of the world population. That is an exceptional 
accomplishment. However, it is currently known that 
concomitantly with the decrease in mortality, several risk 
factors account for the increase in the prevalence of CVD. 
Arterial hypertension, diabetes, dyslipidemia, obesity and 
smoking habit have contributed to a general increase in 
the prevalence of CVD. It is worth noting that, despite the 
significant therapeutic advances, preventive measures, 
mainly the control of risk factors and promotion of healthy 
lifestyles, must be taken. Currently there is scientific evidence 
of the relationship between the implementation of preventive 
strategies and the corresponding reduction in cardiovascular 
events and mortality.6,7 An example is the immediate 
impact of the enforcement of the smoke-free environment 
legislation on the incidence of acute myocardial infarction.8-10 
The reduction in hospitalization rates has been accompanied 
by a significant reduction in mortality rates5 in the acute 
phase and during follow-up, reflecting the disseminated use 
of evidence-based treatments, such as reperfusion therapies 
and drugs to prevent the progression of ischemic heart 
disease. Some of those interventions protect against other 
manifestations of CVD, such as stroke.
The study this editorial refers to confirms those aspects and 
emphasizes the need to develop preventive medicine policies, 
which have clearly shown great efficacy when properly 
implemented. In addition, it portrays, for the first time, a 
vast and robust set of data from countries that share several 
similarities, despite their specific features. The study should 
be properly disclosed to the sanitary authorities of the PSC to 
reinforce the need for measures to reduce the impact of CVD 
on those countries. Above all, it is an excellent example of 
cooperation that should be duly emphasized and replicated. 
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